| 27th week of 2009 patent applcation highlights part 58 |
| Patent application number | Title | Published |
|---|
| 20090170895 | S1P3 RECEPTOR ANTAGONIST - The present invention relates to a medicine, and more particularly to novel arylamidrazone derivatives having an antagonistic action against S1P | 2009-07-02 |
| 20090170896 | c-Met modulators and methods of use - The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazolines and quinolines which inhibit, regulate, and/or modulate kinase receptor, particularly c-Met, KDF, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds. | 2009-07-02 |
| 20090170897 | Method of Treating Neuropathic Pain - The invention relates to the use of a CRTH2 receptor antagonist in the manufacture of a medicament for the treatment of neuropathic pain and to a method of treating neuropathic pain using an antagonist of CRTH2 receptor. | 2009-07-02 |
| 20090170898 | Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor - Compounds of formula (I): | 2009-07-02 |
| 20090170899 | Stimulators of 5-HT4 receptors and uses thereof - The present invention relates to a novel combination of a serotonin selective re-uptake inhibitor (SSRI) and an agonist of the serotonin 4 (5-HT | 2009-07-02 |
| 20090170900 | DOSING REGIMEN FOR WEIGHT LOSS - Disclosed are dosing regimens and methods for the treatment of obesity, overweight and/or overeating in mammals comprising administering to the mammal a pharmaceutically effective amount of a CB1 receptor antagonist as a unit dosage according to a continuous schedule having a dosing interval selected from the group consisting of once-weekly dosing, twice-weekly dosing, thrice-weekly dosing, biweekly and bimonthly. | 2009-07-02 |
| 20090170901 | Benzoyl Urea Derivatives - The new benzoyl urea derivatives of formula (I) wherein the meaning of X and Y independently are hydrogen atom, hydroxy, benzyloxy, amino, nitro, C | 2009-07-02 |
| 20090170902 | COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE - Compounds of formula (I), salts and solvates thereof are provided: | 2009-07-02 |
| 20090170903 | ESTER DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS - The invention provides inhibitors of the phosphodiesterase 4 (PDE4) enzyme. More particularly, the invention relates to compounds that are new ester derivatives, methods of preparing such compounds, compositions containing them, and therapeutic uses thereof. | 2009-07-02 |
| 20090170904 | Substituted benzimidazoles and methods of their use - New substituted benzimidazole compounds, compositions, and methods of inhibition of kinase activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one serine/threonine kinase or receptor tyrosine kinase. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a serine/threonine kinase- or receptor tyrosine kinase-mediated disorder, such as cancer. | 2009-07-02 |
| 20090170905 | SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID - The present invention relates to a substantially crystalline and free solid state form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (Form I), pharmaceutical compositions thereof, and methods of treatment therewith. | 2009-07-02 |
| 20090170906 | HCV INHIBITORS - The present invention relates to compounds that are useful in the treatment of viruses belonging to Flaviviridae, including flaviviruses, pestiviruses, and hepaciviruses. The invention includes compounds useful for the treatment or prophylaxis of dengue fever, yellow fever, West Nile virus, and HCV. | 2009-07-02 |
| 20090170907 | Chemical Compounds - This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds. | 2009-07-02 |
| 20090170908 | SPIRO COMPOUNDS AND PHARMACEUTICAL USE THEREOF - The Spiro compound represented by the following general formula [Ia], its pharmaceutically acceptable salt or a solvate thereof | 2009-07-02 |
| 20090170909 | ALPHA KETOAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS - The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them. | 2009-07-02 |
| 20090170910 | WOUND HEALING - The present invention relates to the use of p38 MAP kinase inhibitors and p38 MAP kinase inhibition to promote wound healing. | 2009-07-02 |
| 20090170911 | NOVEL AZOLE COMPOUND - Azole compounds represented by formula I: | 2009-07-02 |
| 20090170912 | AGENTS FOR COMBATING PLANT PESTS - The present invention relates to compositions for controlling plant pests containing the compound of formula (I) | 2009-07-02 |
| 20090170913 | NOVEL MCH RECEPTOR ANTAGONISTS - The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein Ar | 2009-07-02 |
| 20090170914 | Cermide Kinase Modulation -
A compound of formula (I) wherein R | 2009-07-02 |
| 20090170915 | POLYMORPHIC FORMS OF (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate - The present invention relates to polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)phenyl)ethylcarbamate, pharmaceutical compositions thereof, processes to prepare therein, and uses therewith. | 2009-07-02 |
| 20090170916 | Pyrrole and Pyrazole DAAO Inhibitors - Methods for increasing D-Serine concentration and reducing concentration of the toxic products of D-Serine oxidation, for enhancing learning, memory and/or cognition, or for treating schizophrenia, Alzheimer's disease, ataxia or neuropathic pain, or preventing loss in neuronal function characteristic of neurodegenerative diseases involve administering to a subject in need of treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt or solvate thereof: | 2009-07-02 |
| 20090170917 | Acid Mimic Compounds for the Inhibition of Isoprenyl-S-Cysteinyl Methyltransferase - Among other things, the present invention provides novel compounds capable of effectively inhibiting inflammatory responses that are mediated by G-proteins or GPCRs in neutrophils, macrophages and platelets. In particular, compounds of the present invention act as inhibitors of edema, inhibitors of erythema and inhibitors of MPO (myeloperoxidase), pharmaceutical compositions containing the same compounds and the use thereof for the treatment of diseases that may benefit from edema, erythema and MPO inhibition, such as inflammation (acute or chronic), asthma, autoimmune diseases, and chronic obstructive pulmonary disease (COPD) (e.g., emphysema, chronic bronchitis and small airways disease, etc.), inflammatory responses of the immune system, skin diseases (e.g., reducing acute skin irritation for patients suffering from rosacea, atopic dermatitis, seborrheic dermatitis, psoriasis), irritable bowel syndrome (e.g., Chron's disease and ulcerative colitis, etc.), and central nervous system disorders (e.g., Parkinson's disease). | 2009-07-02 |
| 20090170918 | Solid Formulation of Fungicidal Mixtures - The invention provides highly concentrated WG formulations of fungicidal mixtures, comprising
| 2009-07-02 |
| 20090170919 | METHODS FOR TREATMENT OF INFLAMMATORY DISEASES - An improved method of treating skin diseases comprises applying to the skin of a patient suffering such a skin disease an allantoin-containing composition in a therapeutically effective quantity. The allantoin-containing composition is an oil-in-water emulsion that includes allantoin and an emulsifier system that includes at least one emulsifier that is either an anionic emulsifier or a nonionic emulsifier. The pH of the composition used in a method according to the present invention is from approximately 3.0 to approximately 6.0; a narrower pH range can be used, varying with each embodiment of the composition. | 2009-07-02 |
| 20090170920 | SUBSTITUTED HYDANTOINS - The present invention relates to compounds of the formula | 2009-07-02 |
| 20090170921 | Benzimidazole derivatives - A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof: | 2009-07-02 |
| 20090170922 | Benzimidazole derivatives and their use as a medicament - A subject of the present application is new benzimidazole derivatives of formula | 2009-07-02 |
| 20090170923 | HCV INHIBITORS - The present invention relates to compounds that are useful in the treatment of viruses belonging to Flaviviridae, including flaviviruses, pestiviruses, and hepaciviruses. The invention includes compounds useful for the treatment or prophylaxis of dengue fever, yellow fever, West Nile virus, and HCV. | 2009-07-02 |
| 20090170924 | N-Phenethylcarboxamide Derivatives - A compound of general formula (I): | 2009-07-02 |
| 20090170925 | Methods for prognosing the ability of a zearalenone analog compound to treat cancer - The instant invention provides methods of prognosing the ability of a zearalenone analog compound to treat a cancer in a subject, methods of prognosing the ability of a zearalenone analog compound to inhibit the growth of a cancer in a subject, and methods of prognosing the ability of a zearalenone analog compound to promote the activation of apoptosis of a cancer in a subject. Methods of treating a cancer in a subject are also provided. The invention also pertains to methods of determining whether a cancer in a subject is sensitive to treatment with a zearalenone analog compound. | 2009-07-02 |
| 20090170926 | Antiviral agents - The present invention provides a method of treatment or prophylaxis of hepatitis B virus in a subject comprising administering an effective amount of a compound of formula ( | 2009-07-02 |
| 20090170927 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM - The present invention relates to compounds of formula I, which are functionalized phenolic compounds, and polymers formed from the same. | 2009-07-02 |
| 20090170928 | Synthesis of oligo/poly(catechins) and methods of use - A method for synthesizing a biocompatible, water-soluble oligo/polyflavanoid, includes polymerizing an optionally substituted flavanoid with a polymerization agent in the presence of a biocompatible polymerization solubilizer, thereby producing the biocompatible, soluble oligo/polyflavanoid. Also included is a biocompatible, soluble, oligo/polyflavanoid or a pharmaceutically acceptable salt, solvate, or complex thereof. Also included are methods of treating a subject for cancer, cardiac damage, viral infection, and obesity. | 2009-07-02 |
| 20090170929 | Composition for the Protection and Preservation of Organs, Tissues or Cells and the Use Thereof - The present invention provides a composition for efficiently protecting and preserving organs, tissues or cells. In particular, the present invention provides a protective composition which can be used during operations. Specifically, the present invention provides a composition for protecting and preserving organs, tissues or cells, comprising a polyphenol. A method is also provided for protecting an organ, tissue or cell in a subject, comprising 1) exposing the organ, tissue or cell to a polyphenol. Such a composition and a polyphenol is effective in protecting a function of an organ (particularly, the heart, brain, nerve, spinal cord and the like). | 2009-07-02 |
| 20090170930 | METHODS FOR DIRECTING DIFFERENTIATION OF CLONOGENIC NEURAL STEM CELLS WITH COUMARINS - A method for promoting differentiation of clonogenic neural stem cells (NSCs), comprising administering to a patient in the need of such promoting a coumarin compound represented by formula I or by formula II. The representative coumarin compounds include 7-hydroxycoumarin, daphnoretin, scopoletin, edgeworin, aesculetin and esculetin-6-β-D-glucopyranoside. The coumarin compounds showed significant activity of directing the differentiation of NSCs in pharmacological test and thereof could be used to prepare drugs to direct NSCs differentiated to oligodendrocyte progenitor cells (OPCs) for the treatment of demyelinating diseases or spinal cord injury. The drug could be a pure coumarin compound or a pharmaceutical composition comprising a therapeutical dose of a coumarin compound as active ingredients and a pharmaceutically-acceptable carrier. The content of the active ingredients in the pharmaceutical composition is between 0.1% and 99.5% by weight. | 2009-07-02 |
| 20090170931 | EP2 and EP4 agonists as agents for the treatment of influenza a viral infection - The present invention is directed to the use of EP2 and/or EP4 agonists as therapeutics for the treatment of diseases associated with influenza A viruses, such as for example H5N1 and mutations thereof. | 2009-07-02 |
| 20090170932 | DISINFECTANT COMPOSITIONS, METHODS AND SYSTEMS - Disinfectant compositions comprising N-Acetyl Cysteine (NAC) and Vitamin C are disclosed. The disinfectant compositions have also demonstrated activity in inhibiting as well as killing micro-organisms responsible for generating biofilms. They are safe for human and medical uses and may be used as prophylactic preparations to reduce the proliferation of and/or eliminate existing or established infections. | 2009-07-02 |
| 20090170933 | METHOD FOR REMOVING A MEDICAL DEVICE FROM A SPASMODIC CONSTRICTION IN A BODILY PASSAGEWAY - A method and apparatus for removing a medical device entrapped in a bodily passageway resulting from a spasmodic constriction of bodily tissue surrounding the device involves delivering to the site of the constriction an amount of an antispasmodic agent sufficient to relax the surrounding bodily tissue. The method may also be used for relaxing the tissue of a vessel wall to inhibit constriction of the vessel wall upon the introduction of a medical device into the vessel. | 2009-07-02 |
| 20090170934 | MANUFACTURING PROCESS FOR NO-DONATING COMPOUNDS SUCH AS NO-DONATING DICLOFENAC - The present invention relates to a new process for the preparation of NO-donating compounds using a sulfonated intermediate. The invention relates to new intermediates prepared therein suitable for large scale manufacturing of NO-donating compounds. The invention further relates to the use of the new intermediates for the manufacturing of pharmaceutically active NO-donating compounds. The invention further relates to a substantially crystalline form of NO-donating NSAIDs, especially 2-[2-(nitrooxy)ethoxy]ethyl {2-[(2,6-dichlorophenyl)amino]phenyl}acetate, the preparation thereof and to pharmaceutical formulations containing said crystalline form and to the use of said crystalline form in the preparation of a medicament. | 2009-07-02 |
| 20090170935 | Novel Formulations of Bifenthrin and Enriched Cypermethrin - The present invention is directed to novel insecticidal compositions comprising bifenthrin and enriched cypermethrin, the compositions are physically stable when diluted with water. | 2009-07-02 |
| 20090170936 | Ester Compound and Its Use - An ester compound represented by the formula (1): | 2009-07-02 |
| 20090170937 | Amino Acid Derivatives - Compounds of formula (I) have activity in alleviating the effects of impaired dopaminergic signaling, for example in the treatment of Parkinsons Disease: | 2009-07-02 |
| 20090170938 | FUNGICIDAL ACTIVE INGREDIENT COMBINATION - Active compound combinations comprising an oxime ether derivative of the formula (I) | 2009-07-02 |
| 20090170939 | Use of Fenofibrate or a Derivative Thereof for Preventing Diabetic Retinopathy - This invention relates to the use of fenofibrate or a derivative thereof for the manufacture of a medicament for the prevention and/or treatment of retinopathy. | 2009-07-02 |
| 20090170940 | Modified ethyl formate compositions and methods for soil fumigation - Slow-flow, modified ethyl formate compositions and methods for their use as pre-plant soil fumigants (controlling nematodes and other pathogens) are provided. The modifications include adding to ethyl formate a viscosity modifying thickening agent, and one or more substances which function as a co-solvent and dilution agent (the co-solvent and dilution may or may not be the same). The thickening agent increases the viscosity thereby slowing its flow or rate of transport through the soil. The co-solvent functions as the primary solvent for the viscosity modifying thickening agent. The dilution agent does two things. First, it is used to reduce the partial vapor pressure of the ethyl formate in the formulation, thereby slowing its evaporation rate. Second, it also slows the rate and amount of decomposition of the ethyl formate. The SFMEF compositions and methods do not have harmful ozone-depleting side effects and break down into two naturally-occurring, environmentally-friendly components. Thus they are useful as replacements for methyl bromide and other known ozone-depleting and/or highly toxic soil fumigants. | 2009-07-02 |
| 20090170941 | Pharmaceutical Compounds - Compounds or their salts of general formula (I): A-B—N(O) | 2009-07-02 |
| 20090170942 | ESTER DERIVATIVE AND USE THEREOF - A compound represented by the following formula (I′) | 2009-07-02 |
| 20090170943 | Spider esters in personal care applications - The present invention is drawn to a process for providing emolliency to the skin using a series so called “spider esters”. These esters are derived from poly-hydroxy functional compounds sequentially reacted with ethylene oxide or propylene oxide, followed by the reaction of the alkoxylate with fatty acid. The resulting products are called spider esters because they resemble the spider, wherein appendages are alkoxylated esters. The restrictions this orientation imposes on rotation allows for the preparation of polar esters that have little or no water solubility, and provide both moisturization to the skin and emolliency by reducing transepidermal water loss. | 2009-07-02 |
| 20090170944 | OPHTHALMIC MICELLAR COMPOSITIONS WITH ENHANCED STABILITY - This invention relates to micellar compositions comprising at least one pharmaceutically active substance and a mixture of n-alkyl dimethyl benzyl ammonium chlorides, wherein the mixture comprises more than 30% n-alkyl dimethyl benzyl ammonium chlorides having a chain length superior or equal to C16, wherein the pharmaceutically active substance exhibits an improved stability. In particular, a composition is provided that comprises cetalkonium chloride micelles incorporating the prostaglanding-like therapeutic agent, latanoprost. This invention also relates to ophthalmic compositions containing such micellar compositions and methods of using these ophthalmic compositions for the treatment of eye conditions. | 2009-07-02 |
| 20090170945 | PREGABALIN SALTS - Pregabalin besylate and pregabalin tosylate are pharmaceutically acceptable acid addition salts of pregabalin that are isolatable in solid state, particularly crystalline state, sufficiently soluble in water, and stable both in the solid state and in the solution. | 2009-07-02 |
| 20090170946 | Composition for Mold Remediation - An anti-fungal composition is disclosed and has enhanced microbiocidal activities for killing or inhibiting growth of live mold cells and spores. Further, the composition stops the production of mycotoxins associated with molds. Included among the molds vulnerable to the composition are black mold, | 2009-07-02 |
| 20090170947 | DISINFECTANT COMPOSITIONS, METHODS AND SYSTEMS - Disinfectant compositions comprising PHMB and EDTA salt(s) are disclosed. The disinfectant compositions have also demonstrated activity as enhanced, fast acting catheter lock/flush solutions. They are safe for human and medical uses and may be used as prophylactic preparations to prevent infection, or to reduce the proliferation of and/or eliminate existing or established infections. | 2009-07-02 |
| 20090170948 | Crystal forms of O-desmethylvenlafaxine fumarate - Provided are crystalline forms of O-desmethylvenlafaxine fumarate, methods for their preparation, and pharmaceutical compositions thereof. | 2009-07-02 |
| 20090170949 | Method To Control Body Weight - The present invention relates to a method to treat obesity and/or a method to lose or control body weight. More specifically, the invention relates to the use of a compound inhibiting the sweet taste perception, preferably by inactivating the T1R3 receptor, for the preparation of a medicament to treat or prevent obesity and/or to treat or prevent diabetes and/or to lose or control body weight. | 2009-07-02 |
| 20090170950 | Inhibitors Of Neurotrypsin - The invention relates to a method for determining whether a compound is a neurotrypsin inhibitor, characterized in that the compound is incubated together with neurotrypsin, a variant thereof or a fragment comprising the protease domain and with a protein or peptide comprising agrin, a variant thereof or a fragment comprising the α- or the β-cleavage site of agrin, in an aqueous buffer solution, and the amount of cleavage of agrin is measured. Additionally, the invention relates to inhibitors of neurotrypsin found by this method, in particular to compounds of formula | 2009-07-02 |
| 20090170951 | Phenolic Hydrazone Macrophage Migration Inhibitory Factor Inhibitors - Provided are various compounds of Formula (I): Also provided are pharmaceutical compositions comprising the above compounds. Additionally, methods of inhibiting macrophage migration inhibitory factor (MIF) activity in a mammal are provided, as are methods of treating or preventing inflammation in a mammal. Further provided are methods of treating a mammal having sepsis, septicemia, and/or endotoxic shock. Also provided are methods of treating a mammal having an autoimmune disease, and methods of treating a mammal having a tumor. | 2009-07-02 |
| 20090170952 | COLCHICINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 2009-07-02 |
| 20090170953 | INDENTIFICATION OF COMPOUNDS THAT INHIBIT REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS - The present invention relates to the discovery of a novel class of compounds that inhibit the replication of human immunodeficiency virus (HIV) and approaches to identify these compounds. More specifically, it has been found that enzymatically prepared alpha-hydroxyglycinamide and synthetically prepared alpha-hydroxyglycinamide inhibit the replication of HIV in human serum. Embodiments include methods to identify modified glycinamide compounds that inhibit HIV, methods to isolate and synthesize modified glycinamide compounds, and therapeutic compositions comprising these compounds. | 2009-07-02 |
| 20090170954 | Process for Recovering Florfenicol and Florfenicol Analogs - This invention is generally directed to a method for recovering florfenicol and florfenicol analogs from pharmaceutical compositions. The recovered florfenicol and analogs can be, for example, reused to make new pharmaceutical compositions and thereby reduce the need and expense of manufacturing new florfenicol and florfenicol analogs. | 2009-07-02 |
| 20090170955 | Fast Release Paracetamol Tablets - A pharmaceutical composition such as a swallow tablet or capsule formulation is described comprising paracetamol, calcium carbonate, at least one binding agent and at least one disintegrating agent in the form of a granulate, optionally combined with one or more pharmaceutically acceptable extragranular components. | 2009-07-02 |
| 20090170956 | PREPARATION AND THE USE OF ETHOXY COMBRETASTATINS AND THEIR PRODRUGS - The invention disclosed a total synthesis process of novel ethoxy combretastatins and their prodrugs. Combretastatins are chemically modified by ethoxy substituted on the 4′-position of their B aryl ring and are converted to be their soluble prodrugs of phosphate or their inner salt of phosphorylcholine by modifying the hydroxyl on the 3′-position of their B aryl ring. Similarly, 3′-amino combretastatin is 4′-ethoxy chemically modified and further side chain of amino acid can be introduced to the amino to form soluble prodrug of amino acidamide. The structure of the said compound is showed as formula (I). Ethoxy combretastatins possess potent tubulin polymerization inhibitory activity and can be used for the treatment of inhibiting tumor or neovascular. | 2009-07-02 |
| 20090170957 | SCYLLO-INOSITOL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES CHARACTERIZED BY ABNORMAL PROTEIN FOLDING OR AGGREGATION OR AMYLOID FORMATION, DEPOSITION, ACCUMULATION OR PERSISTENCE - Scyllo-Inositol derivatives represented by structural formula II are described, wherein at least one and not more than five of R | 2009-07-02 |
| 20090170958 | USE OF PARTICULAR POLYMERS OR COPOLYMERS AS SURFACTANTS FOR STABILIZING LATICES - The invention relates to a composition comprising a latex and at least one copolymer that may be obtained via a monomer polymerization process, comprising a step of placing in contact, in a medium comprising water, the said monomer(s) with at least one initiator corresponding, for example, to the formula: | 2009-07-02 |
| 20090170959 | POLYMER CARRIER - Compositions and methods for delivering bioactive agents, such as vitamins, hormones, nutrients and drugs, by stabilizing and or solubilizing these agents in a polymer matrix. The carrier polymers can be used in drug delivery and are useful for delivery of small molecules. The carrier polymers also can be used in scaffolds for regenerative medicine | 2009-07-02 |
| 20090170960 | PEPTIDE LIPID-CONTAINING CARRIER AND METHOD FOR INTRODUCING COMPOUND INTO CELLS USING SAME - The present invention provides a carrier capable of highly efficiently introducing a compound into cells with low cytotoxicity, which contains peptide lipids represented by the following formula, and a method for introducing a compound into cells using the carrier: wherein R | 2009-07-02 |
| 20090170961 | METHOD OF MANUFACTURING DYSPROSIUM OXIDE NANOPARTICLES AND METHOD OF MANUFACTURING DYSPROSIUM OXIDE NANOSOL - Disclosed are a method of manufacturing dysprosium oxide nanoparticles and a method of manufacturing a dysprosium oxide nanosol, which can prepare dysprosium oxide particles having a size of tens of nanometers with high yield by using a simple, low-cost process. The method of manufacturing dysprosium oxide nanoparticles includes preparing a dysprosium salt solution by dissolving a dysprosium salt in a solvent; impregnating an organic polymer comprising a nanosized pore with the dysprosium salt solution; and heating the organic polymer impregnated with the dysprosium salt solution until the organic polymer is fired. | 2009-07-02 |
| 20090170962 | METHODS FOR CONTROLLING DISPERSION OF AQUEOUS SUSPENSIONS - Methods for controlling dispersion of aqueous suspensions involving providing a solvent, and adding at least an additive, an ion source, and a particle source selected from a partially dissolving colloid or a non-dissolving colloid, to the solvent to produce the aqueous suspension where the additive is added to the solvent prior to the ion source and the particle source when the particle source is the partially dissolving colloid. | 2009-07-02 |
| 20090170963 | Process for the Conversion of Hydrocarbons to C2-Oxygenates - The present invention relates to an improved process in term of selectivity and catalyst activity and operating life for the conversion of hydrocarbons to ethanol and optionally acetic acid in the presence of a particulate catalyst, said conversion proceeding via a syngas generation intermediate step. | 2009-07-02 |
| 20090170964 | MEMBRANE REACTOR WITH IN-SITU DEHYDRATION AND METHOD FOR USING THE SAME - A fixed bed membrane reactor is disclosed. The reactor has a housing including an inlet for receiving reactants and an outlet for discharging retentate streams of reaction products. The inlet and outlet are in fluid communication with a reaction zone in which the reactants may passe downstream from the inlet to the outlet with the reactants reacting to produce reaction products including water. The reactor further includes a membrane assembly disposed in fluid communication with the reaction zone. The membrane assembly includes at least one porous support with a water permselective membrane affixed thereto. The membrane allows water produced in the reaction zone to be selectively removed from the reaction zone as a permeate stream while allowing retentate reaction products to remain in the reaction zone and be discharged as a retentate stream. Ideally, the membrane assembly locates most of the membrane proximate the downstream portion of the reaction zone where accumulated produced water may be selectively removed from the reaction product as opposed to the upstream portion where relatively little water accumulation has occurred. A method for using the reactor to perform in situ water dehydration of reactions, such as Fischer-Tropsch reaction, is also disclosed. | 2009-07-02 |
| 20090170965 | ACETYLENE ENHANCED CONVERSION OF SYNGAS TO FISCHER-TROPSCH HYDROCARBON PRODUCTS - A method is disclosed for converting syngas to Fischer-Tropsch (F-T) hydrocarbon products. A synthesis gas including carbon monoxide and hydrogen gas is provided to a F-T reactor. Also, acetylene is supplied to the F-T reactor. The ratio of the volume of acetylene to the volume of synthesis gas is at least 0.01. The synthesis gas and acetylene are reacted under suitable reaction conditions and in the presence of a catalyst to produce F-T hydrocarbon products. The F-T hydrocarbon products are then recovered from the reactor. The synthesis gas and acetylene may be provided in a combined feed stream or introduced separately into the reactor. The acetylene enhanced syngas conversion in a F-T reactor results in the synthesis of F-T products which have a tighter distribution of intermediate length carbon products than do F-T products synthesized according to conventional methods. | 2009-07-02 |
| 20090170966 | Process for the conversion of synthesis gas to oxygenates - The present invention relates to an improved process for the conversion of carbon oxide(s) and hydrogen containing feedstocks to oxygen containing hydrocarbon compounds in the presence of a particulate catalyst. | 2009-07-02 |
| 20090170967 | CONCURRENT OXIDATION AND STEAM METHANE REFORMING PROCESS AND REACTOR THEREFOR - A process for preparation of a synthesis gas and/or hydrogen by concurrently providing an oxidation reactant stream through an oxidation chamber and a reforming reactant stream through a steam, reforming chamber is described. Also provided is a reactor for conducting the reaction. | 2009-07-02 |
| 20090170968 | Processes for Making Synthesis Gas and Syngas-Derived Products - The present invention provides processes for making synthesis gas and processes for making syngas-derived products. For example, one aspect of the present invention provides a process for making a synthesis gas stream comprising hydrogen and carbon monoxide, the process comprising (a) providing a carbonaceous feedstock; (b) reacting the carbonaceous feedstock in a gasification reactor in the presence of steam and a gasification catalyst under suitable temperature and pressure to form a raw product gas stream comprising a plurality of gases comprising methane, hydrogen and carbon monoxide; (c) removing steam from and sweetening the raw product gas stream to form a sweetened gas stream; (d) separating and adding steam to the sweetened gas stream to form a first reformer input gas stream having a first steam/methane ratio; and a second reformer input stream having a second steam/methane ratio, in which the first steam/methane ratio is smaller than the second steam/methane ratio; (e) reforming the second reformer input stream to form a recycle gas stream comprising steam, carbon monoxide and hydrogen; (f) introducing the recycle gas stream to the gasification reactor; and (g) reforming the first reformer input stream to form the synthesis gas stream. | 2009-07-02 |
| 20090170969 | Method for obtaining alkali metal salt aqueous solution of aromatic dihydroxy compound from waste aromatic polycarbonate - There is provided a method for obtaining an aqueous solution of an alkali metal salt of an aromatic dihydroxy compound by decomposing a waste aromatic polycarbonate by an alkali metal hydroxide aqueous solution. The method comprises (1) a dissolution step of dissolving a waste aromatic polycarbonate in a chlorinated hydrocarbon solvent, (2) a decomposition step of adding an alkali metal hydroxide aqueous solution to this solution to decompose the aromatic polycarbonate, (3) a re-dissolution step of adding water to this decomposed solution to dissolve a solid, (4) a two phase formation step of leaving the treated solution obtained in the step (3) to stand to form an organic solvent phase (organic phase) and an aqueous solution phase (aqueous phase), and (5) a separation/collection step of separating the aqueous phase from the organic solvent phase and collecting the aqueous phase. | 2009-07-02 |
| 20090170970 | METHOD OF RECYCLING WASTE PLASTIC FOAM MATERIALS - A method of recycling waste plastic foam materials firstly is to smash a waste material including polyurethane foam into fine particles so as to obtain a first starting material. The first starting material is then crisped and followingly milled into powder so as to obtain a second starting material. The second starting material is then placed into a mixer to mix with a first foaming reaction solution including polyol, catalyst and additives injected into the mixer so as to form a semi-treated foaming material. And then, the semi-treated foaming material is mixed with a second foaming reaction solution including diisocyanate injected into the mixer so as to obtain a completed-treated foaming material. Lastly, the completed-treated foaming material is poured into a mold and then water vapor is uniformly introduced into the mold so as to induce the completed-treated foaming material to proceed foaming reaction. | 2009-07-02 |
| 20090170971 | METHOD FOR MANUFACTURING STARCH FOAM - A method for manufacturing a starch foam is provided. A mixture is mixed to form a foamable mixture. The mixture includes a starch, a nucleating agent, and a foaming agent. The foamable mixture is foamed to form a foam. The starch includes a cereal or a root crop. The cereal includes rice, wheat or corn. The root crop includes cassava, sweet potato or potato. | 2009-07-02 |
| 20090170972 | NATURAL OIL BASED POLYOLS WITH INTRINSIC SURFACTANCY FOR POLYURETHANE FOAMING - The present invention pertains to natural oil based polyols having intrinsic surfactancy and to their use in the production of flexible, viscoelastic and/or semi-rigid, one-shot polyurethane foams with reduced VOC (Volatile Organic Compound) emission. | 2009-07-02 |
| 20090170973 | Macroporous hydrogels, their preparation and their use - A macroporous cryogen is disclosed which has grafted thereon polymer chains formed by polymerizing at least one monomer of the general formula (I) CR1R2=CR3R4 (I) wherein R1 and R2 are equal of different and each represents a hydrogen atom or substituent group which is not detrimental to the polymerization reaction; and R3 and R4 each represents a hydrogen atom or a substituent group which is not detrimental to the polymerization reaction, provided that R3 and R4 are not both a hydrogen atom, on said macroporous cryogel. A method for the preparation of said macroporous cryogel by graft (co)polymerization and the use of said macroporous cryogel in a separation process are also disclosed. | 2009-07-02 |
| 20090170974 | REACTIVE DILUENT FOR ONE OR TWO COMPONENT PU FOAMS - The invention is directed to a polymer foam precursor composition comprising 1 to 60%, preferably 5 to 30% by weight, of a biodiesel obtained by transesterification of vegetable oils. The polymer foam is advantageously a polyurethane foam and the biodiesel is a mixture of methyl and or ethyl fatty acid esters. The biodiesel is a latent hardener and/or extender and/or liquid filler The composition is advantageously used in pressurized vessel or aerosol type cans. | 2009-07-02 |
| 20090170975 | PHOTORADICAL- AND PHOTOCATION-CURABLE COMPOSITION - The present invention has its object to provide a photoradical- and photocation-curable composition improved in curability.
| 2009-07-02 |
| 20090170976 | Polysiloxane-based prepolymer and hydrogel - A polysiloxane-based prepolymer of a three-dimensional network structure produced by hydrolysis-condensation of a first mixture having a tetra-alkoxysilane compound, an ethylenically unsaturated organosiloxane monomer, and a hydrophilic silicon-containing polyfunctional monomer. A hydrogel is prepared by polymerizing a second mixture having the aforesaid polysiloxane-based prepolymer, an acrylated silicon-containing monomer, and an ethylenically unsaturated hydrophilic monomer. | 2009-07-02 |
| 20090170977 | BUILDING BOARD MADE OF MUNICIPAL REFUSE AND AGRICULTURAL PLANT WASTES AND MANUFACTURING METHOD THEREOF - The invention relates to a building board made of municipal refuse and agricultural plant wastes and manufacturing method thereof. The principal raw materials of the board include 200 parts of lightly-burned magnesium powder, 40 to 75 parts of magnesium chloride solution of 28 to 32 Baume degrees, 1 to 2 parts of 36-38% industrial hydrochloric acid, 80 to 120 parts of mineral materials originated from municipal refuse, 20 to 30 parts of agricultural plant wastes, and 50 to 80 parts of fly ash. The manufacturing method of the board includes preparing raw materials, preparing slurry, shaping and curing naturally. The invention uses huge amounts of mineral materials in municipal refuse and agricultural plant wastes as raw materials to making building board, and thereby realizing a recycling of these waste materials. | 2009-07-02 |
| 20090170978 | Curable composition - A curable binder composition comprising an emulsion polymer and a natural binder. | 2009-07-02 |
| 20090170979 | Modified binder polymer for coating compositions - A film-forming binder polymer for a coating composition such as a paint, varnish or woodstain where the polymer is modified by the presence of bonded moieties derived from plant gum, particularly plant fibre gum obtainable from plant fibre, especially corn fibre gum and more particularly moieties derived from proteo-xylans and/or furanose. The modified binder polymer minimises the need to use coalescing solvents without producing poor dried paint coatings which fail the scrub resistance tests also improves the opacity of the dried coating composition. | 2009-07-02 |
| 20090170980 | STABILIZED COATING DISPERSIONS FOR POROUS INKJET RECORDING MEDIA - The invention relates to an inkjet-recording element comprising a support and at least one coated ink-receiving layer, wherein the ink-receiving layer comprises silica particles, optional hydrophilic polymeric binder, and a combination of surfactants, including a fluorosurfactant and a non-fluorine-containing non-ionic surfactant. Also disclosed is a coating composition for such an inkjet recording element. The invention can provide improved image quality (reduced coalescence) of the inkjet recording element or increased stability of the coating composition. | 2009-07-02 |
| 20090170981 | Dispersed composition and process for producing shaped article using the same - A shaped article (e.g., a porous material, and a spherical particle) comprising (A) a resin component is produced by kneading the resin component (A) (e.g., a thermoplastic resin) and a water-soluble auxiliary component (B) to prepare a dispersed composition, and eluting the auxiliary component (B) from the dispersed composition. The auxiliary component (B) may comprise 100 parts by weight of an oligosaccharide (B | 2009-07-02 |
| 20090170982 | Process for Manufacture of Paper Coatings With Improved Water Retention and Brookfield Viscosity Using a Comb Polymer With at Least One Grafted Polyalkylene Oxide Function - The invention concerns a process to manufacture paper coatings containing at least one mineral matter, at least one binder and water, characterised in that at least one comb polymer obtained by grafting of a least one polyalkylene oxide function on to the polymer chain, where the said chain results from the polymerisation of a least one ethylenic unsaturated monomer, is introduced into the above-mentioned composition. | 2009-07-02 |
| 20090170983 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same - A phosphazene compound, which can effectively enhance flame retardancy without deteriorating mechanical properties of a resin molded product, and is also less likely to deteriorate thermal reliability and dielectric properties, is represented by the formula (1) shown below. n represents an integer of 3 to 15. | 2009-07-02 |
| 20090170984 | COMPOSITION CONTAINING POLYMERS, COLOURING AGENTS AND STABILISERS - The invention relates to a composition containing at least one piperidine compound of formula (I) as a stabiliser. In said formula (I) the variables R1, R2, R3, R4, R5, R6, R7, R8, Y and the index n have the meanings cited in claim | 2009-07-02 |
| 20090170985 | POLYESTER-POLYAMIDE COMPOSITIONS, ARTICLES, AND METHOD OF MANUFACTURE THEREOF - A composition is disclosed, comprising, based on the total weight of the composition: from 5 to 60 wt. % of a poly(ethylene terephthalate) having an intrinsic viscosity from 0.5 to 0.9 dl/g; from 0.5 to 10 wt. % of a melamine component; from 5 to 20 wt. % of a halogenated organic flame retarding synergist; from more than 0 to 25 wt % of a polyamide, from 2 to 10 wt. % of an inorganic flame retarding synergist; from 0.1 to 5 wt. % of an anti-dripping agent; and from 10 to 50 wt. % of a reinforcing filler; The invention also relates to articles made from the composition, methods for making the composition, and methods for using the composition. | 2009-07-02 |
| 20090170986 | PIGMENT-BASED INKS WITH IMPROVED JETTING LATENCY - An inkjet ink composition comprising water, pigment particles dispersed with a polymeric dispersant, at least one water-dispersible polyurethane, at least one pyrrolidinone compound, glycerol, and a 1,2-alkanediol having from four to eight carbon atoms. | 2009-07-02 |
| 20090170987 | Process for producing thermoplastic resin composition - An object of the present invention is to provide a process for producing a thermoplastic resin composition with a further improved hue, containing a neutralizing agent, and a compound (I). | 2009-07-02 |
| 20090170988 | STABILIZING SYSTEM FOR HALOGENOUS POLYMERS - A stabilizer system for stabilizing halogen-containing polymers against thermal degradation, the stabilizer system comprising:
| 2009-07-02 |
| 20090170989 | AQUEOUS COLLOIDAL DISPERSIONS STABILIZED WITH POLYMERIC DISPERSANTS - A colloidal pigment dispersion composition comprising: water; dispersed pigment particles; a first polymer dispersant comprising units derived from an acrylate or methacrylate monomer having an alkyl group with 12 or more carbons and units derived from an ethylenicaly unsaturated monomer comprising a carboxylic acid substituent; and a second polymer dispersant comprising units derived from a monomer comprising an aromatic group containing substituent and units derived from an ethylenicaly unsaturated monomer comprising a carboxylic acid substituent, wherein the second polymer dispersant does not comprise units derived from an acrylate or methacrylate monomer having an alkyl group of 12 or more carbons, and wherein the second polymer dispersant has an acid number less than 270. | 2009-07-02 |
| 20090170990 | Stabilized polymer compositions - A composition for stabilizing organic polymers comprising a sterically hindered phenol produced by reacting p-cresol and dicyclopentadiene to produce a precursor and alkylating the precursor with isobutylene, and a tertiary amine oxide. | 2009-07-02 |
| 20090170991 | PNEUMATIC TIRE HAVING A RUBBER COMPONENT CONTAINING EXFOLIATED GRAPHITE - The present invention relates to pneumatic tire having a component including exfoliated graphite intercalated with an elastomer, and at least one additional diene based elastomer. | 2009-07-02 |
| 20090170992 | ETCH RESISTANT POLYMER COMPOSITION - A composite material includes a polymer and a colloidal metal oxide. The composite material has a Plasma Etch Index of 40 relative to a polymer absent the colloidal metal oxide. | 2009-07-02 |
| 20090170993 | FLEXIBLE, LOW DIELECTRIC LOSS COMPOSITION AND METHOD FOR PREPARING THE SAME - A flexible, low dielectric loss composition, used to fabricate a flexible substrate, is provided. The composition includes: SrTiO | 2009-07-02 |
| 20090170994 | Compositions Comprising High Surface Area Ground Calcium Carbonate - Disclosed herein is are compositions comprising ground calcium carbonate having a mean particle size (d | 2009-07-02 |
